Transaction in Own Shares

SHIRE PLC - Transaction in Own Shares

PR Newswire

London, May 30

Transaction in Own Shares

May 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announcesthat, in accordance with the authority granted by shareholders at the Company'sAnnual General Meeting on April 30, 2013, it purchased 90,405 of its ordinaryshares of 5 pence each ("Ordinary Shares") on May 29, 2013 through both directpurchases of Ordinary Shares, and through the purchase of Ordinary Sharesunderlying ADRs. The highest and lowest price paid for the directly acquiredOrdinary Shares was 2200.00 pence per share and 2164.00 pence per sharerespectively, and for those Ordinary Shares acquired though the purchase ofADRs was 3305.67 cents per share and 3280.33 cents per share respectively.

The purchased shares will be held as treasury shares. Following the abovepurchase, the Company holds 8,899,569 Ordinary Shares as treasury shares andhas 553,938,448 Ordinary Shares in issue (excluding treasury shares).

The purchases were made by an independent third party which makes its tradingdecisions independently of, and uninfluenced by, the Company. The independenceof the third party enables the Company to continue to purchase Ordinary Shares(including Ordinary Shares underlying ADRs) during close periods and otherprohibited periods, should they arise. The third party has been appointed bythe Company to make purchases to December 31, 2013.

For further information please contact:

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,Internal Medicine and Regenerative Medicine and we are developing treatmentsfor symptomatic conditions treated by specialist physicians in other targetedtherapeutic areas.

www.shire.com